DOPPELIB
Live / Registered — Registered (as of 25 Aug 2026)
What this means for you
Registered since 25 Aug 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 25 Aug 2032: the §8 declaration of use).
Record
- Serial number
- 99080255
- Registration number
- 8408306
- Mark type
- Word mark
- Filed
- 12 Mar 2025
- Published for opposition
- 07 Jul 2026
- Registered
- 25 Aug 2026
- Next maintenance filing
- §8 declaration of use, due by 25 Aug 2032 (grace period to 25 Feb 2033)
- Attorney of record
- Jeffrey H. Handelsman
Goods and services
- Class 040 — Treatment of materials: Biomanufacturing for others, namely, contract-based purification of antibodies; Biomanufacturing for others, namely, selection and purification of antibodies; Biomanufacturing for others, namely, selection and purification of proteins; Custom manufacturing of cell lines for laboratory, research and development, or medical purposes; Custom manufacturing of cell lines for antibody production; Custom manufacturing of cell lines; Biomanufacturing for others, namely, biomanufacturing of biological cultured tissues for medical, laboratory, or research and development purposes; Biomanufacturing for others, namely, biomanufacturing of biological cultured tissues; Biomanufacturing for others, namely, contract-based biomanufacturing of biological preparations in the nature of proteins; Processing of biological pharmaceutical preparations for others; Treatment of biological pharmaceutical preparations for others; Biomanufacturing for others, namely, selection and purification of biological preparations in the nature of proteins; Contract-based biomanufacturing in the field of pharmaceuticals; Biomanufacturing for others, namely, selection and purification of pharmaceuticals; Biomanufacturing for others, namely, selection and purification of pharmaceutical preparations; Cryogenic preservation of biological tissues; Custom manufacturing of dietary supplements for humans; Food processing; Dietetic food and drink processing; Preservation of antibodies for scientific and medical research and development
- Class 042 — Scientific and technological services: Product research and development services for others in the fields of proteins, antibodies, microorganisms and cells for medical use and consultancy relating thereto; Quality management services, namely, quality control in the fields of proteins, antibodies, microorganisms and cells for medical use and consultancy relating thereto; Research and development services in the field of antibody development technology; Research and development services in the field of antibody technology; Biomedical research services; Design and development of medical technology; Research and development in the field of biotechnology; Pharmaceutical research and development; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations; Scientific research in the nature of conducting clinical trials for others; Technical research services, namely, conducting technical project studies in the field of antibody development technology; Technical research in the field of antibody development technology; Engineering services, particularly technical project planning in the field of antibody development technology; Research and development of new products for others in the medical, scientific, pharmaceutical, biotechnology, and life sciences fields; Design and development of computer software for use with medical technology; Software design and development in the medical, scientific, pharmaceutical, biotechnology, and life sciences fields; Rental of computer software for controlling and managing patient medical information; Providing temporary use of on-line non-downloadable software for controlling and managing patient medical information; Providing virtual computer systems through cloud computing in the medical, scientific, pharmaceutical, biotechnology, and life sciences fields; Scientific laboratory services relating to the acquisition, isolation and cultivation of antibodies, namely, antibodies or antibody-producing cells with desired properties from a population of cells that produce various antibodies; Scientific laboratory services relating to the screening, isolation and cultivation of antibodies, namely, antibodies or antibody-producing cells with desired properties from a population of cells that produce various antibodies, or the acquisition of antibodies or antibody-producing cells with desired properties; Provision of antibodies for scientific and medical research and development
Owner
- CHIOME BIOSCIENCE INC., Tokyo, JP
- CHIOME BIOSCIENCE INC., Tokyo, JP
- CHIOME BIOSCIENCE INC., Tokyo, JP
Prosecution history
- 01 Sept 2026 — POST PUBLICATION AMENDMENT – NOT ENTERED
- 30 Aug 2026 — ASSIGNED TO PETITION STAFF
- 25 Aug 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Aug 2026 — REGISTERED-PRINCIPAL REGISTER
- 28 Jul 2026 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 07 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jul 2026 — PUBLISHED FOR OPPOSITION
- 01 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Jun 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 05 Jun 2026 — EXAMINER'S AMENDMENT ENTERED
- 05 Jun 2026 — EXAMINERS AMENDMENT E-MAILED
- 05 Jun 2026 — EXAMINERS AMENDMENT -WRITTEN
- 31 Mar 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 31 Mar 2026 — FINAL REFUSAL E-MAILED